Tulane scientists find a switch to flip and turn off breast cancer growth and metastasis
Researchers at Tulane University School of Medicine, USA, identified a gene that causes an aggressive…
Browsing: triple-negative breast cancer
ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple-negative breast cancer
Merck has announced positive results from the Phase 3 KEYNOTE-355 trial investigating pembrolizumab in combination with…
Tailoring treatment for triple-negative breast cancer
Immunotherapies have revolutionised treatment for people with a variety of cancers. But when given to…
Experimental drug combination shows potential for triple-negative breast cancer
Researchers from Vanderbilt-Ingram Cancer Center, USA, discovered a role for MYCN in triple-negative breast cancer…
Possible treatment for breast cancer patients could roll out to clinical trial immediately
A worldwide collaborative study led by scientists at the University of Sussex, UK, has proposed…
Both BRCA1-wild type and mutant triple-negative breast cancers show
Oncotarget features “MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S…
Study finds inflammation caused by radiation can drive triple-negative breast cancer
While radiation is successfully used to treat breast cancer by killing cancer cells, inflammation caused…
New insights into cause and treatments for aggressive form of breast cancer
Potential environmental risk factors and new targets for treating an aggressive form of breast cancer…
Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer
Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to…
New hope for aggressive breast cancers as diabetes drug creates treatment ‘sweet spot’
A drug commonly used to treat Type 2 diabetes can force breast cancer ‘stem cells’…